Non-histone lactylation in cancer: current advances and clinical implications - Summary - MDSpire

Non-histone lactylation in cancer: current advances and clinical implications

  • By

  • Yang, Robert Le

  • Liang, Yiran

  • May 18, 2026

  • 0 min

Share

Objective:

To synthesize current advances in non-histone lactylation in cancer, emphasizing its regulatory mechanisms and functional impacts.

Key Findings:
  • Non-histone lactylation modulates protein stability, enzymatic activity, and interactions.
  • Lactylation plays a significant role in tumor biology, influencing proliferation and resistance to therapy.
Interpretation:

Non-histone lactylation represents a promising area for cancer research, linking metabolism and tumor biology.

Limitations:
Conclusion:

The review highlights the complexity and diversity of lactylation mechanisms and their implications in cancer.

Original Source(s)

Non-histone lactylation in cancer: current advances and clinical implications

  • by Yang, Robert Le, Liang, Yiran

  • May 18, 2026

Related Content

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry